BIOMAT Database Logo BIOMAT Database Logo

Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. 1998

M Botney

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

M Botney
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
November 2000, American journal of respiratory and critical care medicine,
M Botney
[Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
January 1999, Revista espanola de anestesiologia y reanimacion,
M Botney
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
March 1987, British heart journal,
M Botney
Epoprostenol (prostacyclin) and pulmonary hypertension.
March 2000, Annals of internal medicine,
M Botney
Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
January 1998, The New England journal of medicine,
M Botney
Epoprostenol therapy for primary pulmonary hypertension.
August 1999, Critical care nurse,
M Botney
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
February 1996, The New England journal of medicine,
M Botney
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
October 2000, Arteriosclerosis, thrombosis, and vascular biology,
M Botney
Epoprostenol in primary pulmonary hypertension.
March 1999, The Annals of pharmacotherapy,
M Botney
Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).
May 1984, Lancet (London, England),
Copied contents to your clipboard!